Keystonemab BV is an AI driven, big-data analytics platform leveraging real-time scientific information from millions of scientific, clinical & patent documents using AI to accelerate translation of knowledge from actionable insights of publications which supports in an unprecedented way.
Our unique fish-net effect enables the identification of other active-ingredients influencing disease related signaling pathways, gene expressions, drug-targets and biomarkers for multi-drug, synergistic approach.
We are specialized in:
Identification of synergistic combinations of drugs and APIs
Design of multi API new drug formulations for superior efficacy
Clinical project rescue (e.g. lack of efficacy) with synergistic combinations
Indication expansion of existing and newly developed drug (Drug repositioning)
Differential biomarker analysis for identification of new druggable targets
Commercial product portfolio analysis for development of market differentiating products
Due diligence for in-licensing novel drugs
Company Details
- Employees
- 5
- Founded
- -
- Address
- Padualaan, Utrecht,3584,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://keystonemab.com/
- Keywords
- Weil am Rhein.
- HQ
- Utrecht
Keystonemab Questions
Keystonemab's website is http://keystonemab.com/
Keystonemab's LinkedIn profile is https://nl.linkedin.com/company/keystonemab
Keystonemab has
5 employees.
View email and phone details for 5
employees at Keystonemab.
Keystonemab's industry is
Biotechnology Research
Keystonemab's top competitors are
Corat Therapeutics Gmbh,
Keystone Europe Bv,
Planet Of Hotels,
Allegiance Health,
Omnium Global,
Glaxo Smithline Pharmaceuticals Ltd,
Medmax Pharma,
Fabp Biotech,
Helios Neopharma,
!leva Sciences Gmbh.
Keystonemab's categories are Biotechnology Research
Keystonemab's founding year is 2019
